RXBIOLOGICS LIMITED
Company number 10590235 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£247,924
Balance sheet as at 2017-11-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-01-30
- Registered office
- The Dorothy Hodgkin Building Babraham Research Campus, Babraham, Cambridge, England, CB22 3FH
- Postcode
- CB22 3FH
- Capital
- 1,000 GBP
- Accounts category
- Small
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-11-30
- Next due by
- 2027-08-31
- Financial year end
- 30 November
Confirmation statement
- Last statement dated
- 2026-01-29
- Next due by
- 2027-02-12
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current
Group structure
Controlled by RXCELERATE LIMITED — since 2017-01-30
From persons-with-significant-control filings on the public register.
Contact details
- Website
- rxbiologics.com
- Phone
- 01223839557
At inception, human antibody phage display technology promised delivery of fully human antibodies, to any given target, directly from ...
Previous company names
| Name | Date changed |
|---|---|
| RX&D LIMITED | 2019-02-07 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| C/O C/O RXCELERATE LIMITED, MONETA BUILDING BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT, UNITED KINGDOM | 2020-08-15 |
Competitors Cambridge
This company ranks 79 among research and experimental development on biotechnology in Cambridge.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.